TOX-knockout tumor-specific T cells1. ACT (transfer of TOX-knockout tumor-specific T cells into tumor models);2. TOX-knockout tumor-specific T cells showed:3. Non-exhausted phenotype;4. Loss of effector function;5. Increased apoptosis;. This evidence concerns the gene TOX and neoplasm.